Novartis drug Lucentis approved by Japanese regulatory bodies
Lucentis® (ranibizumab) has been approved by Japanese regulatory bodies for a fourth indication: the treatment of patients with…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
21 Feb 14
Lucentis® (ranibizumab) has been approved by Japanese regulatory bodies for a fourth indication: the treatment of patients with…
21 Feb 14
The US Preventative Services Task Force (USPSTF) has published a statement indicating that breast cancer antigen (BRCA) testing…
21 Feb 14
Olam International, a leading agri-business operating across the value chain in 65 countries, will be exhibiting its portfolio…
19 Feb 14
Following the announcement of Nestlé SA’s global financial results for 2013, Fiona Kendrick, Nestlé UK & Ireland chairman…
19 Feb 14
Radiation dose, always a concern in CT, is particularly risky for children. Luckily, there is a new way…
18 Feb 14
GlaxoSmithKline (GSK) has announced the start of a Phase III study to evaluate the efficacy and safety of…
18 Feb 14
A new type of MRI scan could present hope for myeloma sufferers, a recent study has found.
17 Feb 14
As point-of-care ultrasound devices become more accurate, the future of the stethoscope is hanging in the balance, according…
17 Feb 14
The Ingredion group of companies has presented its latest clean label innovations at CFIA Rennes 2014.
13 Feb 14
Arla Foods Ingredients has launched Nutrilac® FastRipe, a natural milk protein that enables cheese-makers to reduce ripening times…